Fido's Prescription

More and more, the New York Times' Andrew Pollack writes, people consider their pets to be part of the family and are more willing to spend greater sums to treat them when they fall ill. And biotech entrepreneurs are wondering, why there aren't more treatments available for cats and dogs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.